Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107382867A details a three-step route for high-purity intermediates enabling cost reduction in pharmaceutical manufacturing and supply chain reliability.
Discover a novel preparation method for Ruxolitinib intermediates with >98% ee value. Optimize your supply chain with cost-effective, scalable pharmaceutical intermediate solutions.
Patent CN113943253B reveals optimized Lewis acid catalysis for dexmedetomidine intermediates. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Advanced purification technology for methotrexate intermediates reducing stubborn impurities. Optimized TsOH salt formation ensures high purity and supply continuity.
Patent CN102731351B reveals a phosgene-free route for toltrazuril intermediates, offering safer manufacturing and cost reduction in veterinary chemical production.
Novel patent CN106478531B offers high-purity Lesinurad intermediate synthesis with reduced environmental impact and scalable manufacturing for global supply chains.
Patent CN118955421B introduces a silica gel stirring purification method for Pemafibrate intermediate, replacing column chromatography to ensure high purity and scalability.
Patent CN108069846B reveals a novel resolution method for cis-1-hydroxy-[1,1'-bis(cyclohexyl)]-2-carboxylic acid, eliminating precious metal catalysts for cost-effective pharmaceutical intermediate manufacturing.
Advanced recrystallization patent for Hepatitis C drug intermediates. Delivers high-purity crystals, solvent recovery, and scalable manufacturing for global supply chains.
Novel patent CN103408580B details a safer statins intermediate synthesis route eliminating butyllithium. This offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN121494800A details green synthesis for cefixime intermediate offering high purity and supply chain reliability for pharmaceutical manufacturers.
Patent CN110938069A details a high-purity rivaroxaban intermediate method offering cost reduction and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN1119012A details a safer diborane reduction for paroxetine intermediates. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical ingredients.
Novel preparation method for Alogliptin intermediate using 1,4-difluorobenzene. Reduces cost and improves yield for pharmaceutical manufacturing supply chains.
Patent CN111548341B offers a novel route for lenalidomide key intermediate. Enhanced yield and scalability for pharmaceutical supply chains.
Patent CN104711313A details enzymatic resolution for eldecalcitol intermediates. This method ensures high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101472877A details a scalable route for chiral amino alcohols. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN108383786A details asymmetric hydrogenation for dextromethorphan intermediates. Achieves high yield and purity with reduced costs for reliable pharmaceutical supply chains.
Patent CN115819300B enables high yield synthesis. Reduces toxic reagents. Reliable supply chain partner for pharmaceutical intermediates.
Patent CN104830943A reveals enzymatic resolution for high-purity eldecalcitol intermediate, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturers.